Quantification of the content of cannabinol in commercially available e-liquids and studies on their thermal and photo-stability.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 02 2020
28 02 2020
Historique:
received:
15
05
2019
accepted:
12
02
2020
entrez:
1
3
2020
pubmed:
1
3
2020
medline:
1
3
2020
Statut:
epublish
Résumé
Cannabidiol (CBD) has become a buzzword in many products that have bloomed on the market. The scientific community and some authorities have recently raised concerns on the quality of these products. In particular, the discrepancy between the labelled and the real content of cannabidiol in liquids for e-cigarettes seems to be emerging as a major issue. Furthermore, to-date no studies have been carried out on the chemical stability upon storage of these type of products. The aim of this work was to investigate the accuracy in labelling of thirteen commercially e-liquids containing CBD and the effects of different storage conditions on their quality. The results showed that only 38% of samples were labelled within a ±10% variance from their labels. Stability tests showed a maximum degradation of CBD when samples were stored at 37 °C for 30 days with average values up to 20%. The effect of light was lower but still significant with averages values up to 15% degradation after 30 days. In conclusion, we believe that health authorities should regulate and control this market more stringently to protect customers and their health. Furthermore, our stability tests have shown that if clear indications are provided on the best storage conditions, the quality of these products can be mostly preserved.
Identifiants
pubmed: 32111858
doi: 10.1038/s41598-020-60477-6
pii: 10.1038/s41598-020-60477-6
pmc: PMC7048723
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3697Commentaires et corrections
Type : ErratumIn
Références
Front Pharmacol. 2016 Aug 29;7:279
pubmed: 27621706
Nicotine Tob Res. 2014 Oct;16(10):1319-26
pubmed: 24832759
Cannabis Cannabinoid Res. 2017 Jun 01;2(1):139-154
pubmed: 28861514
Br J Pharmacol. 2008 Jan;153(2):199-215
pubmed: 17828291
J Fam Pract. 2016 Nov;65(11):770-779
pubmed: 28087865
Br J Pharmacol. 2015 Oct;172(20):4790-805
pubmed: 26218440
Pharmacotherapy. 2016 Jul;36(7):781-96
pubmed: 27285147
ACS Omega. 2017 Mar 31;2(3):1207-1214
pubmed: 28393137
JAMA. 2017 Nov 7;318(17):1708-1709
pubmed: 29114823
J Clin Pharmacol. 2002 Nov;42(S1):11S-19S
pubmed: 12412831
Neurobiol Dis. 1998 Dec;5(6 Pt B):534-51
pubmed: 9974182
Chem Phys Lipids. 2002 Dec 31;121(1-2):35-43
pubmed: 12505688
Trends Pharmacol Sci. 2009 Oct;30(10):515-27
pubmed: 19729208
BMJ Open. 2017 Feb 3;7(2):e012784
pubmed: 28159848
Addict Behav. 2017 Jul;70:79-82
pubmed: 28214740
Biomed Environ Mass Spectrom. 1986 Feb;13(2):77-83
pubmed: 2937482